The cessation of dual antiplatelet treatment increased the risk of post coronary intervention adverse events. It is unclear whether the risk varies through time or if it depends on the reason for the interruption or both. The PARIS (patterns of non-adherence to anti-platelet regimens in stented patients) register is a prospective, observational study in patients...
TASTE: Thrombus aspiration in primary angioplasty failed to show benefits at 30 days
The clinical benefit of thrombus aspiration during angioplasty in patients with ST-segment elevation myocardial infarction is uncertain. The purpose of this work was to test if thrombus aspiration reduces mortality. This was a multicenter, prospective, randomized and controlled study that included patients with ST-segment elevation myocardial infarction within 24 hours of evolution. The catheters used...
TAO trial: Otamixaban without advantages as the only anticoagulant in acute coronary syndromes
Despite progress in antiplatelet, anticoagulant therapy and invasive strategy, patients with non-ST-segment elevation acute coronary syndrome present an elevated risk of events. There is no consensus on the use of a single anticoagulant which can be administered in the Coronary Unit and also at the time of coronary intervention. The anticoagulant direct factor Xa inhibitor,...
SOLACI -SIAC collaboration agreement
As the President of the Interamerican Society of Cardiology, (SIAC), I am honored to sign this important agreement with SOLACI. Our societies have an enormous responsibility to improve cardiology in Latin America and we know that this is not an easy task: we are nations with different backgrounds, sometimes different languages and at different stages...
Current hemodialysis patients show similar results for sirolimus-eluting and paclitaxel
Original title: Drug-eluting stents in patients on chronic haemodialysis: Paclitaxel-eluting stents vs. limus –eluting stents Reference: Gabriel l. Sardi, et al. Cardiovasc Revasc Med. 2014 Mar;15(2):86-91. End Stage Renal Disease (ESRD) including renal failure on hemodialysis is associated with coronary heart disease and diabetes with subsequent need for revascularization that in this special population has a high...
Validation of the Bleeding Academic Research Consortium
Reference: Circulation. 2012; 125:1424–143 Abstract: For many years all efforts applied to the optimization of percutaneous coronary intervention (PCI) were aimed specifically at reducing ischemic events risk through the advent of: 1) new devices (medicated stents), reducing restenosis rates, revascularization and 2) development of new drugs with a potent anti-platelet or anticoagulant such as clopidogrel or,...
What is an angioplasty?
An angioplasty is a procedure performed to improve blood flow in the body’s arteries and veins. In an angioplasty procedure, imaging techniques are used to guide a balloon tipped catheter (a very thin tube) into an artery or a vein and advance it to where the vessel is blocked or narrowed. The balloon is then...
What is the difference between a bypass and angioplasty?
We first need to emphasize that both procedures, angioplasty and bypass surgery, are suitable strategies for the treatment of coronary artery disease. In choosing the best alternative to treat their condition, patients usually consult with their physician. Angioplasty is a procedure that uses endovascular techniques, that is to say, through guide wire crossing (what is...
TOTAL Trial: The Best on Manual Thrombectomy in AMI Patients
Original title: Randomized Trial of Primary PCI with or without Routine Manual Thrombectomy. Reference: S.S. Jolly et al. for the TOTAL Investigators. N Engl J Med. 2015 Apr 9;372(15):1389-98. Manual thrombectomy is a routine procedure with ST elevation AMI patients. This common practice proved to reduce mortality in the TAPAS study. However, the TASTE study did not observe...
Educational Journal N° 97
SINDROME CORONARIO AGUDO • Infarto Agudo de Miocardio: Nuevo Paradigma en el tratamiento de STEMI – Dr. Luis Guzmán • Nuevas estrategias de reperfusión miocárdica en el Infarto Agudo de Miocardio con Elevación del Segmento ST – Dr. José Armando Mangione ANGIOPLASTIA TRANSLUMINAL CORONARIA EN SITUACIONES ESPECIALES • ¿Cuál es la mejor estrategia en las bifurcaciones? – Dr....